21st International Congress » Surgical Therapy: Parkinson’s Disease

Date: Monday, June 5, 2017

Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Meeting: 21st International Congress

1:45pm-3:15pm: A Novel Deep Brain Stimulation Programming Paradigm for Parkinson’s disease

J. Karl, L. Verhagen, D. Ocegueda (Chicago, IL, USA)

1:45pm-3:15pm: Action tremor control with deep brain stimulation in patients with Parkinson’s disease: Specific target associations

K. Nozile-Firth, V. Viswanathan, K. Foote, M. Okun, A. Wagle Shukla (Gainesville, FL, USA)

1:45pm-3:15pm: Advanced DBS programming – Multiple Groups : 3yrs experience

g. hosurkar, r. gopalakrishnan (Bengaluru, karnataka, India)

1:45pm-3:15pm: An Objective Tool to Guide Target Selection for DBS in PD (GPi vs STN)

L. Meytin, T.-W. Liang (Philadelphia, PA, USA)

1:45pm-3:15pm: Analysis of the exclusion causes for deep brain stimulation in Parkinson’s Disease Center in southern Taiwan

Y.-F. CHEN, Y.-F. CHEN, C.-C. CHANG, Y. LI, Y.-Y. CHANG (Kaohsiung, Taiwan)

1:45pm-3:15pm: Asymptomatic and transitory postoperative hypodense lesion around deep brain stimulation electrode

M. Sousa, F. Moreira, N. Canário, O. Brito, R. Pereira, M. Rito, C. Januário (Coimbra, Portugal)

1:45pm-3:15pm: Automated DBS Contact Selection using Coherence in Parkinson’s Disease

J. van Zijl, J. Elting, T. van Laar, F. Lange, G. Drost, D. Oterdoom, J. van Dijk, M. Tijssen, M. Beudel (Groningen, Netherlands)

1:45pm-3:15pm: Automatic discrimination between the striatum, Globus pallidus externa and Globus pallidus interna during deep brain stimulation surgery

D. Valsky, H. Bergman, Z. Israel (Jerusalem, Israel)

1:45pm-3:15pm: Baseline characteristics associated with greatest improvement in HRQL after DBS surgery

P. Schmidt, F. Cubillos, C. Martinez-Rubio, K. Lyons, C. Marras, T. Davis, E. Nelson, M. Okun (Miami, FL, USA)

1:45pm-3:15pm: Battery consumption and need for replacement in patients with Parkinson disease treated with interleaved deep brain stimulation

L. Deuel, J. Pilitsis, A. Ramirez-Zamora (Albany, NY, USA)

1:45pm-3:15pm: Clinical utility of chronic directional subthalamic Deep Brain Stimulatoin in Parkinson’s Disease

C. Hartmann, L. Venkatesan, P. Slotty, J. Vesper, A. Schnitzler (Düsseldorf, Germany)

1:45pm-3:15pm: Cognitive effects of GPi versus STN deep brain stimulation in Parkinson’s Disease: experience with patients with moderate cognitive impairment

C. Marques-Matos, C. Sousa, J. Lima, P. Monteiro, P. Linhares, R. Vaz, M.J. Rosas (Porto, Portugal)

1:45pm-3:15pm: Cognitive safety of eight-hours adaptive deep brain stimulation (aDBS) in Parkinson’s disease

R. Ferrucci, F. Ruggiero, F. Cortese, T. Bocci, M. Rosa, M. Arlotti, M. Colombo, S. Marceglia, F. Mameli, F. Cogiamanian, G. Ardolino, M. Locatelli, P. Rampini, A. Priori (Milan, Italy)

1:45pm-3:15pm: Combined Surgical Therapies for Optimal Management of Advanced Parkinson’s Disease

L. Kirkpatrick, Y. Torres-Yaghi, A. Keys, N. Starr, T. Kimbason, C. Moussa, F. Amjad, F. Pagan (Washington, DC, USA)

1:45pm-3:15pm: Comparison of lead localization in postoperative CT versus MRI

R. Nickl, M. Reich, P. Fricke, F. Steigerwald, F. Lange, R.-I. Ernestus, J. Volkmann, C. Matthies (Würzburg, Germany)

1:45pm-3:15pm: Comparison of neuropathology in Parkinson’s disease subjects with and without deep brain stimulation

G. Pal, B. Ouyang, G. Serrano, H. Shill, C. Goetz, G. Stebbins, L. Metman, E. Driver-Dunckley, S. Mehta, J. Caviness, M. Sabbagh, C. Adler, T. Beach (Chicago, IL, USA)

1:45pm-3:15pm: Comparison of pallidal and subthalamic deep brain stimulation in Parkinson’s disease: therapeutic and adverse effects

H.-S. Ryu, M.-S.K. Kim, S. You, M.-J.K. Kim, Y.J. Kim, J. Kim, K. Kim, S.J. Chung (Seoul, Republic of Korea)

1:45pm-3:15pm: Comparison of subthalamic and pallidal deep brain stimulation in treatment of Parkinson’s disease: a 5-year follow-up study

A. Gamaleya, A. Tomskiy, A. Dekopov, E. Bril, A. Poddubskaya, N. Fedorova, V. Shabalov (Moscow, Russian Federation)

1:45pm-3:15pm: Contact location and non-motor outcomes in subthalamic nucleus deep brain stimulation for Parkinson’s disease

D. Floden, C. Matias, C. Wathen, G. Ozinga, O. Hogue, A. Machado (Cleveland, OH, USA)

1:45pm-3:15pm: Correspondence between MRI borders of the subthalamic nucleus and its electrophysiological borders: a comparison study using intraoperative CT.

S. Bus, P. Van den Munckhof, M. Bot, G. Pal, B. Ouyang, S. Sani, L. Verhagen-Metman (Chicago, IL, USA)

1:45pm-3:15pm: Deep brain recording and surgical time in stereotactic and functional neurosurgery for movement disorders

J. Teijeiro Amador, R. Macías, C. Maragoto, N. Quintanal (Havana, Cuba)

1:45pm-3:15pm: Deep Brain Stimulation (DBS) for Parkinson Disease in the Philippines: Outcomes and Practice of the First DBS Center

J.D. Diestro, T. Vesagas, J. Aguilar, R. Teleg, J. Anlacan, R.D. Jamora (Manila, Philippines)

1:45pm-3:15pm: Deep Brain Stimulation for Parkinson Disease before L-dopa treatment: experience in three cases.

d. servello, M. Porta, e. zekaj (Milano, Italy)

1:45pm-3:15pm: Deep Brain Stimulation for Parkinson’s disease: Short-term outcomes, referral patterns and health disparities.

D. Di Luca, V. Aldahondo, W. Jermakowicks, L. Segala, H. Moore, C. Singer, B. Levin, J. Jagid, C. Luca (Miami, FL, USA)

1:45pm-3:15pm: Deep brain stimulation influences on event-related potentials (P300) in Parkinson’s disease

M. Zibetti, S. Palermo, S. Vighetti, A. Romagnolo, L. Lopiano (Torino, Italy)

1:45pm-3:15pm: Degree, onset and longevity of benefit achieved with Deep Brain Stimulation (DBS) of the subthalamic nucleus (STN) as assessed by the UPDRS.

D. Caputo, O. Mark, D. Schneider, R. DiPaola, S. Danish, E. Hargreaves (New Brunswick, NJ, USA)

1:45pm-3:15pm: Directional distribution of subthalamic nucleus beta activity in patients with Parkinson’s disease

G. Tinkhauser, A. Pogosyan, I. Debove, A. Nowacki, H. Tan, K. Petermann, K. Seidel, M. Oertel, C. Pollo, P. Brown, M. Schuepbach (Oxford, United Kingdom)

1:45pm-3:15pm: Disparities in Access to DBS Surgery Based on Demographics of Patients with PD Admitted for DBS Surgery in the United States from 2003 to 2013

F.S. Benesh, S. Gupta, V. Sung (Birmingham, AL, USA)

1:45pm-3:15pm: Displacement of deep brain stimulation (DBS) lead location after implantation: Preliminary result of a study comparing early Vs late CT findings

X.-L. Zhu, C. Lau, C.-M. Cheung, D. Chan, A. Chan, V. Mok, J. Yeung, W. Poon (Hong Kong, China)

1:45pm-3:15pm: Dynamic of symptoms of dopamine dysregulation syndrome after deep brain stimulation in patients with Parkinson`s disease

S. Omarova, N. Fedorova, A. Tomskiy, A. Gamaleya, E. Bril, N. Gubareva (Moscow, Russian Federation)

1:45pm-3:15pm: Dynamics of subthalamic nucleus beta bursts in Parkinson’s disease during ON and OFF dopaminergic state

G. Tinkhauser, A. Pogosyan, H. Tan, A. Kühn, P. Brown (Oxford, United Kingdom)

1:45pm-3:15pm: Effect of bilateral subthalamic nucleus deep brain stimulation on quality of life in advanced Parkinson’s disease patients

s. tandra, B. ramavath, r.m. kandadai, r. borgohain (hyderabad, India)

1:45pm-3:15pm: Effect of deep brain stimulation of the subthalamic nucleus on cranial tremor in Parkinson’s disease

L. Cameron, C. Kilbane, A. Shaikh (Cleveland, OH, USA)

1:45pm-3:15pm: Effects of deep brain stimulation in genetic parkinsonism

L. Oliveira, R. Cury, E. Barbosa (Sao Paulo, Brazil)

1:45pm-3:15pm: Effects of deep brain stimulation on olfactory function in Parkinson’s disease

R. Cury, M. Carvalho, M.g. Santos Ghilardi, A. Estevo, A. de Paiva, F. Lopez, A. Coutinho, M. Teixeira, E. Barbosa, E. Fonoff (São Paulo, Brazil)

1:45pm-3:15pm: Effects of subthalamic and nigral stimulation on gait kinematics in Parkinson’s disease

M. Scholten, J. Klemt, C. Plewnia, B. Bloem, F. Bunjes, R. Krüger, A. Gharabaghi, D. Weiss (Tübingen, Germany)

1:45pm-3:15pm: Efficacy and tolerability of low-frequency deep brain stimulation during daytime only in Parkinson’s disease: a pilot study

F. Dematteis, M. Zibetti, E. Montanaro, L. Rizzi, M. Lanotte, L. Lopiano, M. Rizzone (Torino, Italy)

1:45pm-3:15pm: Eight contacts with multiple-source current steering in pallidal deep brain stimulation for Parkinson’s disease: a non-randomized, single center, open-lavel study

K. Kimura, H. Kishida, N. Ueda, T. Kawasaki, K. Hamada, F. Tanaka (Yokohama, Japan)

1:45pm-3:15pm: Electrode Impedance as a marker for “on” and “off” states in a Deep Brain Stimulation cohort: A pilot study

W. Deeb, J. Shute, M. Okun (Gainesville, FL, USA)

1:45pm-3:15pm: Evaluating Use of the DBS Patient Programmer

D. Whitney, J. Karl, G. Pal, D. Ocegueda-Ramirez, B. Ouyang, L. Verhagen Metman (Chicago, IL, USA)

1:45pm-3:15pm: Excellent Non-motor Responses after Bilateral Subthalamic Deep Brain Stimulation in Parkinson’s Disease Patient with SNCA Duplication

J. Youn, J.W. Cho, J.-I. Lee (Seoul, Republic of Korea)

1:45pm-3:15pm: Expectations and Perceived Outcomes Following DBS for PD: A Case Series

D. Coughlin, M. Hernandez-Con, M. Pavon, M. Spindler, L. Chahine (Philadelphia, PA, USA)

1:45pm-3:15pm: Factors determining the motor outcome of STN DBS in PD patients: Evidence for Dual Actions

C. Lee, E.J. Choi, S.-C. Park, J.K. Lee (Seoul, Republic of Korea)

1:45pm-3:15pm: Feedback Controlled DBS in Parkinson’s Disease using Electrocorticography

N. Swann, C. de Hemptinne, A. Miller, W. Chen, I. Tamir, R Gilron, J. Ostrem, P. Starr (San Francisco, CA, USA)

1:45pm-3:15pm: First experience with 59 directional leads in deep brain stimulation

R. Nickl, P. Fricke, F. Steigerwald, J. Volkmann, C. Matthies (Würzburg, Germany)

1:45pm-3:15pm: GammaKnife subthalamotomy for Parkinson’s disease

t. witjas, r. carron, a. eusebio, j.p. azulay, j. regis (marseille, France)

1:45pm-3:15pm: Health related QoL as measured by the EQ-5D-5L in PD patients after DBS therapy: Preliminary results from the Product Surveillance Registry

M. Schiess, J. Krauss, J.-P. Azulay, E. Cuny, A. Lopez Rios, F. Farrokhi, S. Blond, T. Witt, C. Raftopoulos, J. Vesper, B. Van Dorn, T. Weaver, P. Konrad, S. Falowski, S. Palfi (Houston, TX, USA)

1:45pm-3:15pm: How efficient is subthalamic deep brain stimulation in reducing dyskinesia in Parkinson’s Disease?

N. Kovacs, A. Juhász, I. Balás (Pecs, Hungary)

1:45pm-3:15pm: Improvement of apraxia of eyelid opening in a patient with Parkinson’s disease following the change of the implantable pulse generator for subthalamic nucleus deep brain stimulation .

T. Kadowaki, K. Suzuki, E. Hoshiyama, T. Uchiyama, T. Shingo, K. Hirata (Mibu, Japan)

1:45pm-3:15pm: Interleaved Stimulation for Freezing of Gait in Advanced Parkinson’s Disease: A Pilot Study

R. Rajan, S. Zafer, S. Krishnan, K. Kesavapisharady, A. Kishore (Trivandrum, India, India)

1:45pm-3:15pm: Key clinical milestones 15 years and onwards after DBS-STN surgery – a retrospective analysis of patients that underwent surgery between 1993 and 2001

R. Constantinescu, B. Eriksson, Y. Jansson, B. Johnels, B. Holmberg, T. Gudmundsdottir, A. Renck, P. Berglund, F. Bergquist (Göteborg, Sweden)

1:45pm-3:15pm: Long term tremor benefit from cyst formation as a complication of DBS surgery in a patient with Parkinson’s disease

P. Morrison, I. Richard (Rochester, NY, USA)

1:45pm-3:15pm: Longitudinal changes in speech and voice functions after subthalamic stimulation in Parkinson’s disease patients

T. Tsuboi, H. Watanabe, Y. Tanaka, R. Ohdake, K. Kawabata, K. Hara, D. Nakatsubo, S. Maesawa, Y. Kajita, T. Wakabayashi, M. Katsuno, G. Sobue (Nagoya, Japan)

1:45pm-3:15pm: Maximising decrease in Dopaminergic drugs and increase in ON time following Bilateral STN DBS using constant current for Advanced Parkinsons Disease

S. SANYAL (CALCUTTA (KOLKATA), India)

1:45pm-3:15pm: Meta-analysis of mortality following Subthalamic and Pallidal deep brain stimulation for patients with Parkinson’s disease

A. Negida (Zagazig, El-Sharkia, Egypt)

1:45pm-3:15pm: Neuropsychological predictors of patient-reported cognitive outcomes following deep brain stimulation

K. Mills, K. Donohue, A. Swaminathan, J.-M. Leoutsakos, J. Brandt (Baltimore, MD, USA)

1:45pm-3:15pm: Optimising STN-DBS frequency parameters for improvement of gait with dual tasking in PD patients

R. Borgohain, R. Kandadai, R.P. Peddisetty, J. Kovvuru, S.S. Meka, R. Alagolu, M. Kannan (Hyderabad, India)

1:45pm-3:15pm: Pathological crying induced by deep brain stimulation of the subthalamic nucleus in Parkinsons’ disease

M. Wolf, M. Abdallat, C. Blahak, J. Krauss (Mannheim, Germany)

1:45pm-3:15pm: Patient characteristics vary by DBS indication in Parkinson disease patients

A. Pusso, S. Sperling, M. Harrison, F. Wooten, J. Elias, B. Shah, M. Barrett (Charlottesville, VA, USA)

1:45pm-3:15pm: Pharmaeconomic study of the treatment of advanced Parkinson’s disease.

F. VIVANCOS-MATELLANO, A. SANZ, J.U. MIRÓ, J. CADAVID, A. RUÍZ, N. SOLER (Madrid, Spain)

1:45pm-3:15pm: Postoperative Cognitive Impairment Following Deep Brain Stimulation Surgery

A. Whyte-Rayson, P. Hickey, M. Berger (Durham, NC, USA)

1:45pm-3:15pm: Postoperative delirium after deep brain stimulation surgery for Parkinson’s disease

F. Sasaki, G. Oyama, M. Ito, S. Sekimoto, R. Nakamura, T. Jo, Y. Simo, A. Umemura, N. Hattori (Tokyo, Japan)

1:45pm-3:15pm: Preoperative slowing of EEG and neurocognitive changes following subthalamic nucleus deep brain stimulation in Parkinson’s disease

Y. Higuchi, M. Yakufujiang, Y. Okahara, K. Aoyagi, M. Abe, T. Yamamoto, Y. Yamanaka, S. Hirano, Y. Iwadate (Chiba, Japan)

1:45pm-3:15pm: Probabilistic mapping of deep brain stimulation in Parkinson’s disease.

T. Dembek, J. Roediger, V. Visser-Vandewalle, L. Timmermann, M. Barbe (Cologne, Germany)

1:45pm-3:15pm: Programming deep brain stimulation in the globus pallidus internus for treatment of idiopathic Parkinson’s disease: experience at the University of Kentucky

J. Gurwell, J. Quintero, J. Lamm, J. Slevin, G. Gerhardt, C. van Horne (Lexington, KY, USA)

1:45pm-3:15pm: Quantitative measures of brain MRI as a predictive factor of cognitive outcomes after Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s disease

L. Weinkle, J. Tanabe, B. Hoyt, J. Thompson, J. Honce, O. Klepitskaya (Aurora, CO, USA)

1:45pm-3:15pm: Safe Functional MR Imaging in STN-DBS implanted Parkinson’s disease

M. Saxena, C. McIntyre, B. Walter (Cleveland, OH, USA)

1:45pm-3:15pm: Safety and tolerability of deep brain stimulation in early stage Parkinson’s disease: Five-year follow-up of medication use and adverse events

A. Currie, M. Turchan, L. Heusinkveld, S. Millan, M. Hacker, A. Molinari, C. Gill, T. Davis, P. Konrad, F. Phibbs, P. Hedera, D. Charles (Memphis, TN, USA)

1:45pm-3:15pm: Somnolence as untoward stimulation effect in subthalamic deep brain stimulation (STN DBS) for Parkinson’s disease (PD)

F. Danisi, C. Miller (Poughkeepsie, NY, USA)

1:45pm-3:15pm: Spinal cord stimulation reduces freezing of gait and improves gait in advanced Parkinson’s disease

O. Samotus, N. Kumar, S. Memar, M. Jog (London, ON, Canada)

1:45pm-3:15pm: STN DBS can temporarily improve balance disorders in Parkinson’s disease (PD) patients.

S. Szlufik, M. Kloda, I. Potrzebowska, K. Gregier, A. Friedman, A. Przybyszewski, J. Dutkiewicz, P. Habela, T. Mandat, D. Bialoszewski, D. Koziorowski (Warsaw, Poland)

1:45pm-3:15pm: Tear tumor necrosis factor-alpha levels in patients with Parkinson’s disease: The effect of deep brain stimulation

B. Kocer, S. Comoglu, H. Guven, M. Acar, G. Ozturk (Ankara, Turkey)

1:45pm-3:15pm: The battery longevity of implantable pulse generators (IPG) in Parkinson’s disease (PD) is affected by IPG model, number of previous IPG replacements and stimulation energy delivered.

S. Israeli-Korn, T. Fay-Karmon, S. Tessler, G. Yahalom, S. Benizri, H. Strauss, Z. Zibly, R. Spiegelmann, S. Hassin (Ramat Gan, Israel)

1:45pm-3:15pm: The DBS response ratio: An individual benchmark parameter of DBS quality

L. Lange, M. Reich, R. Nickl, F. Steigerwald, C. Matthies, J. Volkmann (Wuerzburg, Germany)

1:45pm-3:15pm: The non-motor symptoms in Parkinsons’s disease patients treated with STN DBS: the follow up study

M. Mencinger, M. Červek, T. Rus, G. Jakob, D. Georgiev, D. Flisar, R. Rajnar, M. Benedičič, K. Boetzel, J. Mehrkens, Z. Pirtošek, M. Trošt (Ljubljana, Slovenia)

1:45pm-3:15pm: Twiddler Syndrome in Deep Brain Stimulation

N. Durmaz Celik, M. Vural, S. Ozkan (Eskişehir, Turkey)

1:45pm-3:15pm: UPDRS benefit from dual frequency DBS fields sculpted by intentionally overlapped interleaving

Y. Fernandez, D. Caputo, D. Schneider, R. Dipaola, S. Danish, E. Hargreaves (New York, NY, USA)

1:45pm-3:15pm: UPDRS III score and RS latency can determine the possible neuromodulative role of STN DBS in Parkinson’s disease (PD) patients

S. Szlufik, A. Przybyszewski, J. Dutkiewicz, P. Habela, T. Mandat, D. Koziorowski (Warsaw, Poland)

1:45pm-3:15pm: Weight Changes in STN and GPi Deep Brain Stimulation: Long Term Follow up

S. Shah, L. Almeida, A. Patterson, J. Hilliard, A. Wagle Shukla, K. Foote, M. Okun, D. Martinez-Ramirez, P. Zeilman (Gainesville, FL, USA)

« View all sessions from the 21st International Congress.